Ernest K Amankwah1, Christie M Atchison2, Shilpa Arlikar1, Irmel Ayala3, Laurie Barrett4, Brian R Branchford5, Michael Streiff6, Clifford Takemoto7, Neil A Goldenberg8. 1. Clinical and Translational Research Organization, All Children's Research Institute, All Children's Hospital Johns Hopkins Medicine, St. Petersburg, FL, USA. 2. Undergraduate Medical Education, Department of Pediatrics, University of South Florida Morsani College of Medicine, Tampa, FL, USA. 3. Johns Hopkins Medicine Pediatric Thrombosis Program, All Children's Hospital and Johns Hopkins Children's Center, St. Petersburg, FL and Baltimore, MD, USA. 4. Clinical and Translational Research Organization, All Children's Research Institute, All Children's Hospital Johns Hopkins Medicine, St. Petersburg, FL, USA; Johns Hopkins Medicine Pediatric Thrombosis Program, All Children's Hospital and Johns Hopkins Children's Center, St. Petersburg, FL and Baltimore, MD, USA. 5. Section of Hematology/Oncology/Bone Marrow Transplantation, Department of Pediatrics, University of Colorado School of Medicine Anschutz Medical Campus and Children's Hospital Colorado, Aurora, CO, USA. 6. Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 7. Johns Hopkins Medicine Pediatric Thrombosis Program, All Children's Hospital and Johns Hopkins Children's Center, St. Petersburg, FL and Baltimore, MD, USA; Division of Hematology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 8. Clinical and Translational Research Organization, All Children's Research Institute, All Children's Hospital Johns Hopkins Medicine, St. Petersburg, FL, USA; Johns Hopkins Medicine Pediatric Thrombosis Program, All Children's Hospital and Johns Hopkins Children's Center, St. Petersburg, FL and Baltimore, MD, USA; Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Division of Hematology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: neil.goldenberg@allkids.org.
Abstract
OBJECTIVE: To determine hospital-associated venous thromboembolism (HA-VTE) risk factors in critically ill neonates. METHODS: We conducted a case-control study in the neonatal intensive care unit (NICU) of All Children's Hospital Johns Hopkins Medicine (St. Petersburg, FL), from January 1, 2006 - April 10, 2013. We identified HA-VTE cases using electronic health record. Four NICU controls were randomly selected for each HA-VTE case. Associations between putative risk factors and HA-VTE were estimated using odds ratios (ORs) and ninety-five percent confidence intervals (95%CIs) from univariate and multivariate regression analyses. RESULTS: Twenty-three HA-VTE cases and 92 controls were included. The annual HA-VTE incidence was approximately 1.4 HA-VTE cases per 1,000 NICU admissions. In univariate analyses, mechanical ventilation (OR=7.27, 95%CI=2.02-26.17, P=0.002), central venous catheter (CVC; OR=52.95, 95%CI=6.80-412.71, P<0.001), infection (OR=7.24, 95%CI=2.66-19.72, P<0.001), major surgery (OR=5.60, 95%CI=1.82-17.22, P=0.003) and length of stay ≥15days (OR=6.67, 95%CI=1.85-23.99, P=0.004) were associated with HA-VTE. Only CVC (OR=29.04, 95%CI=3.18-265.26, P=0.003) remained an independent risk factor in the multivariate analysis. Based on this result, the estimated risk of HA-VTE in NICU patients with a CVC was 0.9%. CONCLUSION: This study identifies CVC as an independent risk factor for HA-VTE in critically ill neonates. However, the level of risk associated with CVC is below the conventional threshold for primary anticoagulation thromboprophylaxis. Larger studies are needed to substantiate these findings and identify novel putative risk factors to further distinguish NICU patients at highest HA-VTE risk.
OBJECTIVE: To determine hospital-associated venous thromboembolism (HA-VTE) risk factors in critically ill neonates. METHODS: We conducted a case-control study in the neonatal intensive care unit (NICU) of All Children's Hospital Johns Hopkins Medicine (St. Petersburg, FL), from January 1, 2006 - April 10, 2013. We identified HA-VTE cases using electronic health record. Four NICU controls were randomly selected for each HA-VTE case. Associations between putative risk factors and HA-VTE were estimated using odds ratios (ORs) and ninety-five percent confidence intervals (95%CIs) from univariate and multivariate regression analyses. RESULTS: Twenty-three HA-VTE cases and 92 controls were included. The annual HA-VTE incidence was approximately 1.4 HA-VTE cases per 1,000 NICU admissions. In univariate analyses, mechanical ventilation (OR=7.27, 95%CI=2.02-26.17, P=0.002), central venous catheter (CVC; OR=52.95, 95%CI=6.80-412.71, P<0.001), infection (OR=7.24, 95%CI=2.66-19.72, P<0.001), major surgery (OR=5.60, 95%CI=1.82-17.22, P=0.003) and length of stay ≥15days (OR=6.67, 95%CI=1.85-23.99, P=0.004) were associated with HA-VTE. Only CVC (OR=29.04, 95%CI=3.18-265.26, P=0.003) remained an independent risk factor in the multivariate analysis. Based on this result, the estimated risk of HA-VTE in NICUpatients with a CVC was 0.9%. CONCLUSION: This study identifies CVC as an independent risk factor for HA-VTE in critically ill neonates. However, the level of risk associated with CVC is below the conventional threshold for primary anticoagulation thromboprophylaxis. Larger studies are needed to substantiate these findings and identify novel putative risk factors to further distinguish NICU patients at highest HA-VTE risk.
Authors: Clifford M Takemoto; Sajeet Sohi; Kruti Desai; Raman Bharaj; Anuj Khanna; Susan McFarland; Sybil Klaus; Alia Irshad; Neil A Goldenberg; John J Strouse; Michael B Streiff Journal: J Pediatr Date: 2013-12-12 Impact factor: 4.406
Authors: Brian W Gray; Raquel Gonzalez; Kavita S Warrier; Lauren A Stephens; Robert A Drongowski; Steven W Pipe; George B Mychaliska Journal: J Pediatr Surg Date: 2012-06 Impact factor: 2.545
Authors: Sheila J Hanson; Rowena C Punzalan; Marjorie J Arca; Pippa Simpson; Melissa A Christensen; Sydney K Hanson; Ke Yan; Kristin Braun; Peter L Havens Journal: J Trauma Acute Care Surg Date: 2012-05 Impact factor: 3.313
Authors: Julie Jaffray; Arash Mahajerin; Brian Branchford; Anh Thy H Nguyen; E Vincent S Faustino; Michael Silvey; Stacy E Croteau; John H Fargo; James D Cooper; Nihal Bakeer; Neil A Zakai; Amy Stillings; Emily Krava; Ernest K Amankwah; Guy Young; Neil A Goldenberg Journal: Pediatr Crit Care Med Date: 2022-01-01 Impact factor: 3.971
Authors: J C Bohnhoff; S A DiSilvio; R K Aneja; J R Shenk; Y A Domnina; B S Brozanski; M Good Journal: J Perinatol Date: 2016-12-01 Impact factor: 2.521
Authors: Ahmed Mousa; Ossama M Zakaria; Ibrahim Hanbal; Mohammed A Nasr; Tamer A Sultan; Mohamed Abd El-Hamid; Amr M El-Gibaly; Haytham Al-Arfaj; Ahmed S Daha; Mohammed A Buhalim; Mohamed Y Zakaria; Dina E El Metwally; Bosat E Bosat; Alaa Sharabi; Mohamed Nienaa; Mahsoub M Amin; Khaled A Rashed Journal: Clin Appl Thromb Hemost Date: 2018-12-06 Impact factor: 2.389